[Guidelines for the treatment of childhood IgA nephropathy]

Nihon Jinzo Gakkai Shi. 2008;50(1):31-41.
[Article in Japanese]
No abstract available

Publication types

  • Practice Guideline

MeSH terms

  • Angiotensin II Type 1 Receptor Blockers / administration & dosage
  • Angiotensin II Type 1 Receptor Blockers / adverse effects
  • Angiotensin-Converting Enzyme Inhibitors / administration & dosage
  • Angiotensin-Converting Enzyme Inhibitors / adverse effects
  • Anticoagulants / administration & dosage
  • Child
  • Drugs, Chinese Herbal / administration & dosage
  • Drugs, Chinese Herbal / adverse effects
  • Glomerulonephritis, IGA / therapy*
  • Glucocorticoids / administration & dosage
  • Glucocorticoids / adverse effects
  • Humans
  • Immunosuppressive Agents / administration & dosage
  • Immunosuppressive Agents / adverse effects
  • Phytotherapy
  • Platelet Aggregation Inhibitors / administration & dosage
  • Platelet Aggregation Inhibitors / adverse effects
  • Prednisolone / administration & dosage
  • Prednisolone / adverse effects
  • Severity of Illness Index
  • Tonsillectomy

Substances

  • Angiotensin II Type 1 Receptor Blockers
  • Angiotensin-Converting Enzyme Inhibitors
  • Anticoagulants
  • Drugs, Chinese Herbal
  • Glucocorticoids
  • Immunosuppressive Agents
  • Platelet Aggregation Inhibitors
  • sairei-to
  • Prednisolone